Open AccessCOVID-19 Infection with Refractory Diabetic Ketoacidosis- A case Report
Author(s) -
Reshmi Mishra,
Jyoti Ranjan Behera,
P. Ramkumar,
Mukesh Kumar Jain
Publication year - 2021
Publication title -
the journal of medical research
Language(s) - English
Resource type - Journals
ISSN - 2395-7565
DOI - 10.31254/jmr.2021.7206
Subject(s) - diabetic ketoacidosis , medicine , diabetes mellitus , metabolic acidosis , refractory (planetary science) , ketoacidosis , acidosis , complication , intensive care medicine , disease , pediatrics , insulin , covid-19 , renal replacement therapy , type 1 diabetes , endocrinology , infectious disease (medical specialty) , physics , astrobiology
Diabetic ketoacidosis is an acute life-threatening complication of type 1 diabetes. Sometimes it is the first presentation in an undiagnosed child. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) and diabetes mellitus are very much interrelated as diabetes mellitus is associated with an increased risk of severe COVID19 at the same time, many cases of new-onset diabetes had been diagnosed. Hyperglycemia, metabolic acidosis, and ketonemia are classical presentations. It is essential to correct the acidosis and fluid correction and insulin therapy in these patients, leading to vital organ dysfunction. In refractory metabolic acidosis, renal replacement therapy may help
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom